Episode Details
Back to Episodes
The Skylight 2 Study Findings - Dr. Nanette Santoro
Season 1
Published 3 years, 3 months ago
Description
Join researcher and clinician Dr. Nanette Santoro to review the findings of the Skylight 2 study on fezolinentant and her expectations of approval of a 45 mg daily oral dose to treat VMS in women.
After listening to this podcast, please visit menopauselearning.com to claim your free CME accreditation.
After listening to this podcast, please visit menopauselearning.com to claim your free CME accreditation.